Cat. No.
MABL-6218
Application
BLI, dot blot, functional assays, IP, IF
Isotype
Engineer antibody
Species Reactivity
Human, Mouse
Clone No.
OLF46
From
Recombinant Antibody
Specificity
This antibody is specific for natively folded olfactomedin (OLF) domain of myocilin, recognizes a discontinuous conformational epitope. Strictly binds properly‑folded monomeric OLF; no binding to unfolded, denatured or aggregated OLF. OLF is C‑terminal β‑propeller domain (human residues 245‑504), prone to misfolding/amyloid formation in glaucoma‑related mutants. Epitope locates on propeller blade near amyloid‑prone P1 region; cross‑reactive to human and mouse myocilin OLF domains.
Alternative Names
Myocilin 55 kDa subunit; Trabecular meshwork‑induced glucocorticoid response protein; MYOC; OLF domain; anti‑OLF2
UniProt
Q99972; O70624
Immunogen
Original antibody generated by immunizing BALB/c mice with purified human Myoc‑OLF domain, followed by heterologous boosting with mouse and human OLF. Mouse phage‑display scFv library was built and panned against human and mouse Myoc‑OLF.
Application Notes
Characterized in chimeric human IgG1 and Fab formats. Gives very weak signal under denaturing WB, consistent with conformational epitope. Dot‑blot & ELISA only recognize folded monomeric OLF. Fab fragment shows low‑nanomolar affinity via BLI (\(K_D=5.61\pm0.07\ nM\)). IP recovers full‑length secreted myocilin from primary human trabecular meshwork cell conditioned medium. Potently inhibits OLF amyloid aggregation; 1:1 molar ratio fully suppresses human Myoc‑OLF aggregation within 24 h, effective for up to 96 h (both IgG and Fab work). In HTM‑1 / HEK293T cellular glaucoma‑mutant models, it re‑routes ER‑trapped mutant myocilin, reduces intracellular amyloid aggregates; aggregate clearance depends on lysosome‑autophagy pathway (blocked by bafilomycin A1, not proteasome inhibitor) (WO2021237213; Ma et al., 2024; PMID:39726989). First published in PNAS Nexus, 2024; paper describes recombinant antibodies clearing ER‑resident glaucoma‑causing myocilin aggregates via autophagy.
Antibody First Published
Ma et al. Antibody-mediated clearance of an ER-resident aggregate that causes glaucoma PNAS Nexus. 2024 Dec 10;4(1):pgae556. doi: 10.1093/pnasnexus/pgae556. PMID:39726989
Note on publication
The original publication reports the development of recombinant antibodies targeting the aggregation-prone olfactomedin domain of mutant myocilin that promote autophagy-mediated clearance of ER-resident aggregates.
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.


